Cargando…

Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B

OBJECTIVE: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination. PATIENTS AND METHODS: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019, throug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corsini Campioli, Cristina, Esquer Garrigos, Zerelda, Assi, Mariam, Go, John Raymond, Razonable, Raymund R., Beam, Elena, Yao, Joseph, Cummins, Nathan W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240146/ https://www.ncbi.nlm.nih.gov/pubmed/34195546 http://dx.doi.org/10.1016/j.mayocpiqo.2020.10.010

Ejemplares similares

Vaccination and transient hepatitis B surface antigenemia
por: Mohan, Dhanya, et al.
Publicado: (2011)

290. Hepatitis E Virus Serostatus: A Retrospective Assessment of Demographics and Comorbidities to Assess High-risk Populations
por: Stone, Eric C, et al.
Publicado: (2019)

2044. Utility of Serum Β-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2018)

Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease
por: Corral, Juan E, et al.
Publicado: (2020)

Chronic Kidney Disease and Hepatitis B Virus Surface Antigenemia
por: Lee, Sung Woo, et al.
Publicado: (2018)

Follow-Up of Newborns with Hepatitis B Antigenemia
por: Qi, Jing, et al.
Publicado: (2022)

Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

21. Current and Nadir CD4+ Counts Are Associated with Heplisav-B Seroprotection Rates in People with HIV
por: Schnittman, Samuel, et al.
Publicado: (2020)

Routine Donor and Recipient Screening for Mycoplasma hominis and Ureaplasma Species in Lung Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2022)

1637. Improving Transitions of Care in the Division of Infectious Diseases
por: Paim, Ana, et al.
Publicado: (2018)

Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature
por: Apostolopoulou, Anna, et al.
Publicado: (2020)

COVID-19 Pathogenesis and Clinical Manifestations
por: Hernandez Acosta, R. Alfonso, et al.
Publicado: (2022)

Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria
por: Kolawole, Olatunji M, et al.
Publicado: (2012)

Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study
por: Kwon, Joshua Y., et al.
Publicado: (2023)

Prevalence and Determinants of Hepatitis B Antigenemia in 15 007 Inmates in Taiwan
por: Lin, Ching-Feng, et al.
Publicado: (2010)

Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular‐matrix envelope
por: Sohail, M. Rizwan, et al.
Publicado: (2020)

Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future
por: Xiang, Kun, et al.
Publicado: (2021)

False-Positive Hepatitis B Antigenemia After Vaccination in a Patient With CKD
por: Khoo, Benjamin Zhi En, et al.
Publicado: (2021)

Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

Prevalence of hepatitis B e antigenemia in Bahraini hepatitis B patients: A retrospective, single‐center study
por: Abdulla, Maheeba, et al.
Publicado: (2021)

332. Phaeohyphomycosis Due to Scopulariopsis brumptii in a Hematopoietic Stem Cell Transplant (HSCT) Recipient
por: Syed, Sadia, et al.
Publicado: (2018)

660. Extraction-Free 16S Ribosomal RNA (rRNA) Gene Amplification and Sequencing from Resected Cardiac Implantable Electronic Device (CIED) Sonicate Fluid
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2019)

Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis
por: Vance, Mary Kathryn, et al.
Publicado: (2023)

454 Cytomegalovirus (CMV) Disease after Lung Transplantation (LT) is associated with increased mortality despite Extended Antiviral Prophylaxis
por: Beam, Elena, et al.
Publicado: (2014)

Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines
por: Ziaee, Masoud, et al.
Publicado: (2010)

2287. Recently Approved HEPLISAV-B(R) [Hepatitis B Vaccine (Recombinant), Adjuvanted] Shows a Higher Proportion of Subjects Achieving Seroprotection With a More Consistent Immune Response Compared With Engerix-B(R) [Hepatitis B Vaccine (Recombinant)] in Three Comparative Trials
por: Hyer, Randall N, et al.
Publicado: (2018)

Abstract 144: Breast Implant Infections After Reconstruction: Clinical Characteristics Associated With Specific Microorganisms
por: Banuelos, Joseph, et al.
Publicado: (2020)

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
por: Girndt, Matthias, et al.
Publicado: (2022)

2029. Comparison of Primers Amplifying Two Different Regions of the 16S Ribosomal RNA Gene for Microbiologic Diagnosis of Cardiovascular Implantable Electronic Device Infection
por: Garrigos, Zerelda Esquer, et al.
Publicado: (2018)

Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
por: Corsini Campioli, Cristina, et al.
Publicado: (2020)

Rotavirus Antigenemia in Children Is Associated with Viremia
por: Blutt, Sarah E, et al.
Publicado: (2007)

Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis
por: Ordaya, Eloy E, et al.
Publicado: (2022)

Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
por: Ordaya, Eloy E., et al.
Publicado: (2023)

Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge
por: Bierle, Dennis M., et al.
Publicado: (2021)

92. Utility of Sinus CT in the Evaluation of Patients with Febrile Neutropenia
por: Gurram, Pooja, et al.
Publicado: (2020)

Successful outcome of a pregnancy in a woman with advanced cirrhosis due to hepatitis B surface antigenemia, delta super-infection and hepatitis C co-infection: a case report
por: Subhan, Amna, et al.
Publicado: (2007)

Circulating rotaviral RNA in children with rotavirus antigenemia
por: Ahmed, Kamruddin, et al.
Publicado: (2013)

Antigenemia without antigenuria in a cat with histoplasmosis
por: Jarchow, Anthony, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lgfth2lc10vc29pl76scurknvn